Lyra Therapeutics (NASDAQ:LYRA) Price Target Cut to $11.00 by Analysts at Bank of America : vimarsana.com

Lyra Therapeutics (NASDAQ:LYRA – Free Report) had its price target trimmed by Bank of America from $12.00 to $11.00 in a research report released on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock. LYRA has been the subject of several other reports. HC Wainwright reiterated a buy rating and issued […]

Related Keywords

United States , Texas , America , , Tower Research Capital , Heritage Wealth Management Inc , Jpmorgan Chase Co , Cantor Fitzgerald , Lyra Therapeutics Inc , York Mellon Corp , Goldman Sachs Group Inc , Lyra Therapeutics , Free Report , Therapeutics Stock Down , Research Capital , Wealth Management , Sachs Group , New York Mellon Corp , Get Free Report , Lyra Therapeutics Daily , Nasdaq Lyra , Lyra , Medical , Lower Price Target , Bank Of America Co ,